Ledipasvir/sofosbuvir
Ledipasvir/Sofosbuvir
Ledipasvir/Sofosbuvir (pronunciation: leh-dih-PASS-vir/soh-FOSS-buh-vir) is a fixed-dose combination medication used in the treatment of hepatitis C. It combines ledipasvir and sofosbuvir, two antiviral medications that prevent hepatitis C virus (HCV) from multiplying in the body.
Etymology
The name "Ledipasvir" is derived from the chemical name L-methyl-edine-parazine-sulfonamide-virus inhibitor. "Sofosbuvir" is derived from the chemical name Sodium fosphate butyrate virus inhibitor.
Usage
Ledipasvir/Sofosbuvir is used to treat chronic hepatitis C, a viral infection of the liver. It is used in adults and children aged 12 years and older, or weighing at least 77 pounds (35 kilograms).
Related Terms
- Hepatitis C: A viral infection that causes liver inflammation, sometimes leading to serious liver damage.
- Antiviral: Medications used specifically for treating viral infections.
- Sofosbuvir: An antiviral medication that prevents hepatitis C virus (HCV) from multiplying in your body.
- Ledipasvir: An antiviral medication that prevents hepatitis C virus (HCV) from multiplying in your body.
Side Effects
Common side effects of Ledipasvir/Sofosbuvir include tiredness, headache, and difficulty sleeping. Serious side effects may include a slow heart rate and a reactivation of hepatitis B.
Precautions
Before taking Ledipasvir/Sofosbuvir, tell your doctor or pharmacist if you are allergic to either drug; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems.
External links
- Medical encyclopedia article on Ledipasvir/sofosbuvir
- Wikipedia's article - Ledipasvir/sofosbuvir
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski